CAJ | 학술논문

目的:探讨CA125,CA19-9联合检测诊断宫颈腺癌的临床意义.方法:32例经病理证实为宫颈腺癌的患者于入院时和手术后4周进行CA125,CA19-9联合检测.结果:官颈腺癌患者血清CA125和CA19-9含量及阳性率明显升高.CA125的敏感性为75%,特异性为92.6%;CA19-9的敏感性为46.9%,特异性为96.3%.CA125和CA19-9联合检测敏感性提高至81.3%,特异性没有明显下降.结论:CA125联合检测CA19-9可明显提高诊断的灵敏度,对诊断宫颈腺癌和预后估测有一定价值.
목적:탐토CA125,CA19-9연합검측진단궁경선암적림상의의.방법:32례경병리증실위궁경선암적환자우입원시화수술후4주진행CA125,CA19-9연합검측.결과:관경선암환자혈청CA125화CA19-9함량급양성솔명현승고.CA125적민감성위75%,특이성위92.6%;CA19-9적민감성위46.9%,특이성위96.3%.CA125화CA19-9연합검측민감성제고지81.3%,특이성몰유명현하강.결론:CA125연합검측CA19-9가명현제고진단적령민도,대진단궁경선암화예후고측유일정개치.